A medical worker takes a swab sample from a woman for COVID-19 test at a testing site in Nanjing, east China’s Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Ji Chunpeng)
A medical worker takes a swab sample from a woman for COVID-19 test at a testing site in Nanjing, east China’s Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Ji Chunpeng)
People register for COVID-19 test at a testing site in Nanjing, east China’s Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Ji Chunpeng)
A medical worker takes a swab sample from an elderly man for COVID-19 test at a testing site in Nanjing, east China’s Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Li Bo)
People queue for COVID-19 test at a testing site in Nanjing, east China’s Jiangsu Province, July 21, 2021. Nanjing, which has a population of more than 9.3 million, carried out citywide nucleic acid testing starting on Wednesday. (Xinhua/Li Bo)
Source: http://www.xinhuanet.com/english/2021-07/22/c_1310076322.htm
0 Comments